Poster: CT-163 Outcomes of Hematological Malignancy Patients Who Underwent Haploidentical SC Transplant With ATG of 2 Mg/kg Based Conditioning Regimen

Momen Nassani,Walid Rasheed,Majed Altareb, Ali Alsharif,Feras Alfraih,Amr Hanbali,Saud Alhayli,Syed Osman Ahmed,Abdulwahab A. Albabtain,Marwan Shaheen,Naeem Chaudhri,Fahad Alsharif,Alfadel Alshaibani,Ahmad S. Alotaibi,Tusneem Elhassan,Fahad Almohareb,Ali Alahmari,Hazzaa Alzahrani,Mahmoud Aljurf,Riad El Fakih

Clinical Lymphoma Myeloma and Leukemia（2022）

引用 0|浏览19

暂无评分

摘要

Haplo-HSCT for hematological malignancies with myeloablative conditioning, PTCY and ATG 2 mg/kg is feasible and associated with favorable OS, and RFS. The risk of GVHD, VOD, and GF is comparable to other case series.

查看译文

关键词

CT,haploidentical transplant,anti-thymocyte globulin,post-transplant cyclophosphamide,hematological malignancies,myeloablative conditioning

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要